Horizons: Perspectives on Psychedelics conference recap

by Numinus

Dec 21, 2021

Listen to this episode

In this episode of the Psychedelic Therapy Frontiers podcast, Dr. Steve Thayer and Dr. Reid Robison give a report on their recent trip to the Horizons: Perspectives on Psychedelics conference in New York. They discuss the following topics:

(1:40) Horizons: Perspectives on Psychedelics
(1:52) MeetDelic conference 
(6:00) The diverse ways in which psychedelic medicine is being research and brought to the people
(8:33) MAPS Public Benefit Corporation 
(10:42) Proposed REMS for MDMA-assisted psychotherapy for PTSD
(16:33) Oregon Psilocybin Services Act ballot measure 109
(18:19) The challenges of combing ancient practices with modern medicine and giving credit where credit is due and cultural appropriation
(21:40) Enthea non-profit dedicated to proving insurance coverage for psychedelic therapies
(23:19) North Star
(29:10) Laying the groundwork for the delivery of psychedelic medicine once it's FDA approved
(33:14) Gul Dolen's research on “Critical periods” for learning and change opened up by psychedelics 
(38:13) Matt Johnson's research grant
(38:55) How to Do the Work, by Nicole LePera
(40:10) Be cautious about making big changes immediately following a psychedelic experience
(42:33) Psychedelics, mindfulness, and contemplative practices episode
(44:20) TiHKAL and PiHKAL
(46:13) Hamilton Morris and 5MEO-DMT
(49:55) Usona Research Institute

Email us questions and feedback at psychfrontiers@novamind.ca 
Learn more about our podcast at https://www.psychedelictherapyfrontiers.com/
Learn more about Novamind at https://www.novamind.ca/

Disclaimer: The content of this podcast does not constitute medical advice or mental health treatment. Consult with a medical/mental health professional if you believe you are in need of mental health treatment.

We want to connect with you!

Sign up here so we can keep in touch.